Literature DB >> 31971403

Psychosocial screening and mental health in pediatric cancer: A randomized controlled trial.

Maru Barrera1, Sarah Alexander2, Eshetu G Atenafu3, Joanna Chung1, Kelly Hancock1, Aden Solomon1, Leandra Desjardins1, Wendy Shama4, Denise Mills2.   

Abstract

OBJECTIVE: Diagnosis and treatment of childhood cancer can impact the mental health of the family. Early psychosocial risk screening may help guide interventions. The primary aim of this study was to evaluate if an intervention (providing psychosocial risk information to the patient's treating team) would result in decreased depression symptoms in caregivers, in general, and relative to initial psychosocial risk. A secondary aim was to examine intervention effects in a small sample of patient and sibling self-reported outcomes.
METHODS: We randomly allocated families to the intervention group (IG, treating team received PAT summary) or control group (CG, no summary). One hundred and twenty-two caregivers of children newly diagnosed with cancer completed measures of depression and anxiety and psychosocial risk 2-4 weeks from diagnosis (T1) and 6 months later (T2). Patients and siblings completed self-report measures of depression and anxiety.
RESULTS: There was no significant difference in caregiver depression symptoms between the IG and CG at T2. However, in the context of psychosocial risk, caregivers in the IG showed improvement in depression scores compared to CG when risk was high near diagnosis (Ms = 6.68 vs. 9.76, respectively, d = .60). Similar results were found in anxiety scores. Intervention effects with patients and siblings were inconclusive.
CONCLUSIONS: Sharing psychosocial risk information with the treating team had measurable impact on mental health outcomes only if caregivers had initial high psychosocial risk. This study contributes to our understanding of mapping psychosocial screening and resources to improve outcomes in families managing childhood cancer. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 31971403     DOI: 10.1037/hea0000825

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  4 in total

1.  Using formative evaluation to plan for electronic psychosocial screening in pediatric oncology.

Authors:  Jordan Gilleland Marchak; Sean N Halpin; Cam Escoffery; Shadé Owolabi; Ann C Mertens; Karen Wasilewski-Masker
Journal:  Psychooncology       Date:  2020-10-20       Impact factor: 3.894

2.  Implementation of family psychosocial risk assessment in pediatric cancer with the Psychosocial Assessment Tool (PAT): study protocol for a cluster-randomized comparative effectiveness trial.

Authors:  Anne E Kazak; Janet A Deatrick; Michele A Scialla; Eric Sandler; Rebecca E Madden; Lamia P Barakat
Journal:  Implement Sci       Date:  2020-07-29       Impact factor: 7.327

3.  Using qualitative and participatory methods to refine implementation strategies: universal family psychosocial screening in pediatric cancer.

Authors:  Janet A Deatrick; Anne E Kazak; Rebecca E Madden; Glynnis A McDonnell; Katherine Okonak; Michele A Scialla; Lamia P Barakat
Journal:  Implement Sci Commun       Date:  2021-06-05

4.  Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial.

Authors:  Leandra Desjardins; Kelly Hancock; Peter Szatmari; Sarah Alexander; Wendy Shama; Claire De Souza; Denise Mills; Oussama Abla; Maru Barrera
Journal:  Pilot Feasibility Stud       Date:  2021-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.